Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

The market size for devices of minimally invasive glaucoma surgery (migs) has seen an impressive surge in recent times. Its growth is projected to rise from $0.7 billion in 2024 to $0.89 billion in 2025, with a compound annual growth rate (CAGR) of 27.6%. The remarkable growth during the historic period could be credited to heightened awareness towards averting blindness, enhanced healthcare infrastructure investments, better informed patients about cutting-edge vision correction treatments, a rising understanding of advanced vision correction therapies, and increased governmental initiatives.

In the near future, the market size for minimally invasive glaucoma surgery (MIGS) devices is anticipated to witness a remarkable growth. The market is projected to surge to $2.29 billion by 2029 with a compound annual growth rate (CAGR) of 26.5%. The growth during the projection period can be ascribed to factors such as escalating incidences of ophthalmologic conditions like glaucoma, increased old age population, enhancement in healthcare infrastructure and the escalating requirement for safe and effective treatments. The projected period also shows trends such as the uptake of MIGS devices, technological advancements, the implementation of pioneering minimally invasive glaucoma surgery devices, the advent of state-of-the-art implantable devices, and progress in ophthalmic technology.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp

What Drivers Are Accelerating Expansion Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

The escalating incidence of eye-related health issues is predicted to stimulate the expansion of the minimally invasive glaucoma surgery (MIGS) devices market. These eye disorders include numerous conditions impacting eye health and vision. The rise in these issues is attributed to shifts in lifestyle, environmental factors, and ageing populations. MIGS devices serve as innovative instruments in treating a variety of eye diseases, with a primary focus on diminishing intraocular pressure (IOP) to halt or manage the progression of glaucoma. The National Eye Institute, a government agency in the US, predicts that about 2.2 million Americans will become blind or partially sighted by 2030, further highlighting the increasing need for these solutions. Therefore, the growing incidence of eye disorders stimulates the market for minimally invasive glaucoma surgery (MIGS) devices.

How Is The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmented Across Key Categories?

The minimally invasive glaucoma surgery (migs) devicesmarket covered in this report is segmented –

1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products

2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma

3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets

4) By Distribution Channel: Direct Tender, Retail Sales

5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users

Subsegments:

1) By Valves: Micro Shunt Valves, Non-penetrating Valves

2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants

3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt

4) By Stents: Ab-Interno Stents, Ab-Externo Stents

5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices

What Key Trends Are Driving Growth In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

Major businesses prevalent in the Minimally Invasive Glaucoma Surgery (MIGS) devices industry are concentrating their efforts on inventing novel products such as stent injectable systems. These endeavors aim to meet the unresolved challenges of glaucoma management and enhance patient prognosis. Stent injectable systems are MIGS devices which implant minor stents into the body through a procedure akin to injection, frequently employing a distinct delivery mechanism oftentimes used in minimally invasive operations to treat issues like obstructed or constricted blood vessels. For instance, in August 2022, the U.S. Food and Drug Administration (FDA) bestowed Glaukos Corporation – an ophthalmic medical technology firm based in the US – with a 510(k) clearance for their iStent Infinite Trabecular Micro-Bypass System. The iStent Infinite is an innovative three-stent injectable system devised to offer foundational, round-the-clock intraocular pressure (IOP) control for patients diagnosed with primary open-angle glaucoma (POAG), who haven’t responded to prior medication and surgical treatments.

Which Companies Are Contributing Significantly To The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth?

Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Incorporated Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Staar Surgical Company, Glaukos Corporation, Sight Sciences Inc., Ocular Therapeutix Inc., Iridex Corporation, Ellex Medical Lasers Ltd., New World Medical Inc., MicroSurgical Technology Inc., Nova Eye Medical Limited, Asico LLC, Ziemer Ophthalmic Systems AG, Transcend Medical, iSTAR Medical SA, Ivantis Group Inc., Allergan, InnFocus Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Which Region Dominates The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Today?

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model